Noninvasive intranasal stem cells bypass the blood-brain barrier to target the brain to treat Parkinson's disease, stroke, MS, brain tumors, cerebral ischemia, Alzheimer's and other CNS disorders

William H. Frey II

Center for Memory & Aging (Alzheimer's Research Center) Regions Hospital, 640 Jackson St., St. Paul, MN 55101 Professor of Pharmaceutics, Neurology and Neuroscience University of Minnesota alzheimr@umn.edu Cell phone: 651-261-1998


Noninvasive intranasal stem cells bypass the blood-brain barrier to target the brain to treat Parkinson's disease, stroke, MS, brain tumors, cerebral ischemia, Alzheimer's and other CNS disorders

Noninvasive intranasal stem cells bypass the blood-brain barrier to target the brain to treat Parkinson's disease, stroke, MS, brain tumors, cerebral ischemia, Alzheimer's and other CNS disorders

 

William H. Frey II

 

Journal of Nature and Science, 1(1):e23, 2015.

 

---------------------------------------------------------------

How to cite this article? Here is an example:

 

Frey II WH (2015) Noninvasive intranasal stem cells bypass the blood-brain barrier to target the brain to treat Parkinson's disease, stroke, MS, brain tumors, cerebral ischemia, Alzheimer's and other CNS disorders. Journal of Nature and Science, 1(1):e23.

 

Click here for more options

 




HomeAbout JNSCI Privacy PolicyPeer ReviewPub Fee
Ads FeeAuthor Guidance

漏2019 Journal of Nature and Science (JNSCI), Los Angeles, CA, USA | ISSN 2377-2700 | Contact: editor@jnsci.org